Bausch Health Companies (TSE:BHC) Trading Down 7.2% - What's Next?

Key Points

• Bausch Health Companies' stock price fell by 7.2%, trading as low as C$7.64 and closing at C$8.21, with trading volume down by 18% from average levels.
• Director John Paulson purchased 1,782,030 shares at C$8.14 each, contributing to a total insider acquisition of 3.55 million shares worth about $27 million in the last quarter.
• The company has a market cap of C$2.14 billion, a negative P/E ratio of -12.01, and a high debt-to-equity ratio of -1,831.94.

Bausch Health Companies Inc. (TSE:BHC - )'s share price dropped 7.2% during mid-day trading on Thursday . The stock traded as low as C$7.64 and last traded at C$8.21. Approximately 290,869 shares were traded during trading, a decline of 18% from the average daily volume of 353,949 shares. The stock had previously closed at C$8.85.

Bausch Health Companies Stock Down 7.2%

The firm has a fifty day simple moving average of C$8.10 and a 200-day simple moving average of C$8.60. The firm has a market cap of C$2.14 billion, a price-to-earnings ratio of -12.01, a P/E/G ratio of 0.21 and a beta of 0.77. The company has a debt-to-equity ratio of -1,831.94, a quick ratio of 0.58 and a current ratio of 1.19.

Insiders Place Their Bets

In other news, Director John Paulson acquired 1,782,030 shares of the stock in a transaction on Friday, June 13th. The shares were purchased at an average price of C$8.14 per share, for a total transaction of C$14,501,803.73. In the last quarter, insiders acquired 3,553,401 shares of company stock worth $27,087,675. 11.28% of the stock is owned by company insiders.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.